期刊文献+

骨细胞相关因子在骨重建中的作用 被引量:2

The Role of Osteocyte-related Factors in the Bone Remodeling
下载PDF
导出
摘要 骨细胞是一种动态的、具有复杂功能的细胞,也是骨组织中含量最丰富、分布最广泛的细胞。近几年研究发现,骨细胞在骨重建中的调节作用越来越明显,其分泌的骨硬化蛋白、RANKL及OPG是调节骨形成和骨吸收的重要调控因子。骨细胞特异性地分泌的骨硬化蛋白对骨形成具有特殊的抑制效果,主要机制是结合LRP5/LRP6,从而阻止经典Wnt信号通路。而骨硬化蛋白的单克隆抗体则通过拮抗其作用而保证Wnt信号通路的正常传导,引起骨形成、骨密度和骨强度增加。骨细胞同样会分泌RANKL及OPG,两者在生理和病理条件下直接或间接调节破骨细胞分化和功能,调控骨重吸收。该文就这一领域近年研究现状和发展方向作一综述。 As the most abundant and the most widely distributed in bone tissue, osteocytes are dynamic cells, with complex function. Recent studies have revealed that osteocytes play multiple important physiological roles, secreting many regulatory factors, such as osteosclerosis protein, receptor activator of the NF-kB ligand (RANKL) and osteoprotegerin (OPG). These factors play important roles in regulating bone formation and bone resorption. The sclerostin, is expressed at significant levels by osteocytes, interacts with Lrp5 and Lrp6 and inhibits the canonical Wnt signaling pathway. Sclerostin monoclonal antibody ensures Wnt pathway conducting normally by inhibiting sclerostin, increasing bone formation, bone mineral density and bone strength. Osteocytes also secretes RANKL and OPG, both of which regulating differentiation and function of osteoclasts directly or indirectly, in Physiological and pathological conditions, regulating bone reabsorption. In this paper, we make a review about the research status and development direction.
出处 《中国医学创新》 CAS 2015年第7期150-153,共4页 Medical Innovation of China
基金 2013年贵州省科技厅 遵义医学院 遵义市科技局联合基金项目(黔科合J字LKZ[2013]43号)
关键词 骨细胞 骨重建 骨硬化蛋白 RANKL OPG Osteocyte Bone remodeling Sclerostin RANKL OPG
  • 相关文献

参考文献31

  • 1Knothe Tate M L,Adamson J R,Tami A E,et al.The osteocyte[J].The International Journal of Biochemistry&Cell Biology,2004,36(1):1-8.
  • 2孟芮,王海芳,续惠云,骞爱荣,曹建平,商澎.骨细胞功能研究进展[J].细胞生物学杂志,2008,30(2):161-165. 被引量:16
  • 3Igwe J C,Gao Q,Kizivat T,et al.Keratocan is expressed by osteoblasts and can modulate osteogenic differentiation[J].Connective Tissue Research,2011,52(5):401-407.
  • 4Bonewald L F.The amazing osteocyte[J].Journal of Bone and Mineral Research,2011,26(2):229-238.
  • 5Liu S,Gupta A,Quarles L D.Emerging role of fibroblast growth factor23 in a bone–kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization[J].Current Opinion in Nephrology and Hypertension,2007,16(4):329-335.
  • 6Poole K E S,van Bezooijen R L,Loveridge N,et al.Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation[J].The FASEB Journal,2005,19(13):1842-1844.
  • 7Bellido T,Ali A A,Gubrij I,et al.Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes:a novel mechanism for hormonal control of osteoblastogenesis[J].Endocrinology,2005,146(11):4577-4583.
  • 8Moester M J C,Papapoulos S E,Lowik C,et al.Sclerostin:current knowledge and future perspectives[J].Calcified Tissue International,2010,87(2):99-107.
  • 9Lin C,Jiang X,Dai Z,et al.Sclerostin Mediates bone response to mechanical unloading through antagonizing Wnt/β-catenin signaling[J].Journal of Bone and Mineral Research,2009,24(10):1651-1661.
  • 10Rhee Y,Allen M R,Condon K,et al.PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling[J].Journal of Bone and Mineral Research,2011,26(5):1035-1046.

二级参考文献39

  • 1Manolagas SC. Bonekey Osteovision, 2006, 3:5.
  • 2Kurata K et al. J Bone Miner Res, 2006, 21:616.
  • 3Kim HJ et al. J Clin Invest, 2006, 116:2152.
  • 4Taylor AF et al. Am J Physiol Cell Physiol, 2007, 292:C545.
  • 5Vezeridis PS et al. Biochem Biophys Res Commun, 2006, 348:1082.
  • 6Heino TJ et al. Exp Cell Res, 2004, 294:458.
  • 7van Bezooijen RL et al. Cytokine Growth Factor Rev, 2005, 16: 319.
  • 8Vashishth D et al. Bone, 2000, 26:375.
  • 9Verborgt O et al. J Bone Miner Res, 2000, 15:60.
  • 10Burger EH et al. FASEB J, 1999, 13:S101.

共引文献15

同被引文献74

  • 1Raisz LG.Mechamisms and regulation of bone resorption by osteoclastic cell. In:coe FL,Favus M.Disorder of bone and mineral metabolism, Connecticut; Raven Press, 1992:287.
  • 2Sudo H,Kodama HA,AmagaiY, et al.ln vitro differentiation andcalcification in a new Clonal osteogenic cell line derived fromnew born mouse calvaria.Cell Biol. 1983;96(1 ): 191-198.
  • 3Mombeli A, Umurn R,Lang NP, et aI.Actinobacilus actinomycetemcomitans in Chinese adults. Serotype distribution and analysis of the leukotoxin gene promoter LocusoJ Clin Periodontl. 1999;26(8) 505.
  • 4Weinberg E.Iron loading:a risk factor for osteoporosis. BioMetals.2009; 19(6): 633-635.
  • 5Lai YL,Yamaguchi MEffects of copper on bone component in the femoral tissues of rats: anaboliceffect of zinc is weakened by copper.Biol Pharm Bu11.2005;28(12): 2296-2301.
  • 6Odabasi E,Turan M,Aydin A,et aI.Magnesium, zinc, copper, manganese, and selenium levels in postmenopausal women with osteoporosis, can magnesium play a key role in osteoporosis.Ann Acad Med Singapore.2008;37:564-567.
  • 7Seo HJ,Cho YE,Kim T, et aI.Zinc may increase bone formation through stimulating cell proliferation,alkaline phosphatase activity and collagen synthesis in osteoblastic MC3T3-E1 cells.Nutr Res Pract. 2010;4(5):356-361.
  • 8EI-Ayoubi R,Eliopoulos N,Diraddo R,et al.Design and fabrication of 3D porous scaffolds to facilitate cell-based gene therapy.Tissue Eng Part A. 2008; 14(6):1037-1048.
  • 9Nilsang S,Nehru V, Plieva FM,et al.Three- dimensional culture for monoclonal antibody production by hybridoma cells immobilized in macroporous gel particles.Biotechnol Prog. 2008; 24(5): 1122-1131.
  • 10Bokhari MA,Akay G, Zhang S,et aLThe enhancement of osteoblast growth and differentiation in vitro on a peptide hydrogel- p01yHIPE polymer hybrid material. Biomaterials. 2005;26(25): 5198-5208.

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部